Why Pfizer And Eli Lilly Are Betting On This $1.3 Billion AI Drug Discovery Startup

Image for article Why Pfizer And Eli Lilly Are Betting On This $1.3 Billion AI Drug Discovery Startup
News Source : Forbes

News Summary

  • Chai Discovery is working with major drugmakers to use its latest antibody AI model to find new therapies.
  • Now it’s in talks to raise $400 million more VC funding at a $3.4 billion valuation.
  • In January, the startup announced a deal with Eli Lilly, the $1 trillion (market cap) drug behemoth best known for its weight-loss drugs.
  • Chai is in talks with more than 15 additional pharma companies, and hopes to sign more deals this year.

Must read Articles